Achieving the right balance between GLP1R, GIPR and GR agonisation , would in principle be able to achieve even greater losses in weight, while still preserving lowering of blood glucose
Accurate structure prediction of biomolecular interactions with AlphaFold 3
Gestational diabetes is coded in the obstetrics chapter, not with E codes
In this blog post, we will delve into the current scientific evidence and the potential therapeutic applications of IV glutathione
For obesity therapeutics, Phase 3 trials are especially important because regulators want to see: Long-term weight loss sustainability Cardiovascular safety Real-world tolerability Effects on obesity-related conditions such as diabetes, sleep apnea, and osteoarthritis Retatrutides Phase 3 program, called TRIUMPH , includes multiple large-scale studies across different patient populations